Castle Biosciences to Present New DecisionDx®-SCC and DecisionDx®-Melanoma Data at the American Head & Neck Society's (AHNS) 11th International Conference on Head and Neck Cancer
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, will present new data on its gene expression profile risk-stratification test for patients...
Source: marketscreener.com